Genenta Science S.p.A. (NasdaqCM: SAEN)
Health Care · Biotechnology · IT
$0.58
+0.85% today · -70.8% 1Y
Genenta Science S.p.A. (NasdaqCM: SAEN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $28.06M and employs 9 people.
Over the last twelve months the share price has lost 70.8%, trading between 0.55 and 2.58.
Tweenvest scores Genenta Science S.p.A. across four factors: quality 40/100, value 48/100. Its strongest factor is value.
SAEN price history
Key figures
- Market cap
- $28.06M
- Revenue (TTM)
- —
- P/E
- -3.81
- EPS
- -0.39
- Dividend yield
- —
- Beta (5Y)
- 0.77
- 52-week high
- $2.58
- 52-week low
- $0.55
- Avg volume (3M)
- —
- Shares outstanding
- 48.22M
- Employees
- 9
- Next earnings
- —
About Genenta Science S.p.A.
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
- ISIN
- US36870W1009
- Founded
- 2014
- Listed since
- Dec 15, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Amplia Therapeutics LimitedASX: ATX | $28.42M | AU$0.08 | -1.20% |
| Microbix Biosystems Inc.TSX: MBX | $28.29M | CA$0.30 | +1.72% |
| Edesa Biotech, Inc.NasdaqCM: EDSA | $28.10M | $2.08 | -6.31% |
| ProMIS Neurosciences, Inc.NasdaqCM: PMN | $28.07M | $3.13 | -2.49% |
| Anti-Microbial Savior BioteQ Co., Ltd.TPEX: 6864 | $28.04M | NT$37.00 | -1.07% |
| Immunotech Biopharm LtdSEHK: 6978 | $27.94M | HK$0.36 | -1.39% |
| Polyrizon Ltd.NasdaqCM: PLRZ | $27.88M | $11.48 | +4.20% |
| Enimmune CorporationTPEX: 6564 | $27.48M | NT$15.10 | +0.67% |